Prevention: The Ultimate Goal

Robert C. Young When I was growing up, my whole generation was haunted by the fear of polio. We all knew people who suffered from this disease and died, or were confined to iron lungs. But a vaccine changed the course of medical history and made polio a preventable disease. Likewise with cancer, the future of research rests not with making the equivalent of a better iron lung, but instead with the development of scientific strategies to prevent the disease. Despite dramatic advances in our

Written byRobert Young
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share


Robert C. Young
When I was growing up, my whole generation was haunted by the fear of polio. We all knew people who suffered from this disease and died, or were confined to iron lungs. But a vaccine changed the course of medical history and made polio a preventable disease. Likewise with cancer, the future of research rests not with making the equivalent of a better iron lung, but instead with the development of scientific strategies to prevent the disease.

Despite dramatic advances in our scientific understanding of cancer and substantial improvements in our ability to treat it medically, cancer continues to exact a devastating personal and financial toll on society. Approximately 8.4 million Americans alive today have a history of cancer. This year alone in the United States, cancer will strike 1,220,100 people and will claim more than 552,000 lives--more than 1,500 people a day.

Researchers have long hoped ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies